mechanism of action glp-1 agonist Receptor Agonists as Treatments for Type 2 Diabetes Frontiers | GLP-1 Receptor Agonists:
Description
( Epub 20190325 )
He notes that in humans GLP-1 reduces pancreatic inflammation and rarely increases amylase and lipase to more than the 3- fold increase which is needed to meet diagnostic criteria for pancreatitis
Its taken as a tablet or capsule, usually once a day before breakfast, and its a Schedule IV controlled substance because of its potential for abuse and dependence
While the full picture is still emerging, the breadth of these effects underscores why expectations for this drug class have soared
2016;13(6): e1002051
Your diet quality makes a difference
